Y-mAbs Therapeutics Inc (YMAB)
10.10
-0.44
(-4.17%)
USD |
NASDAQ |
Nov 21, 16:00
10.12
+0.02
(+0.20%)
After-Hours: 20:00
Y-mAbs Therapeutics Market Cap: 452.37M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 452.37M |
| November 20, 2024 | 472.08M |
| November 19, 2024 | 486.41M |
| November 18, 2024 | 480.14M |
| November 15, 2024 | 498.95M |
| November 14, 2024 | 519.11M |
| November 13, 2024 | 590.32M |
| November 12, 2024 | 590.32M |
| November 11, 2024 | 666.01M |
| November 08, 2024 | 693.34M |
| November 07, 2024 | 696.47M |
| November 06, 2024 | 702.74M |
| November 05, 2024 | 676.32M |
| November 04, 2024 | 666.01M |
| November 01, 2024 | 660.19M |
| October 31, 2024 | 649.57M |
| October 30, 2024 | 664.79M |
| October 29, 2024 | 659.86M |
| October 28, 2024 | 663.00M |
| October 25, 2024 | 648.22M |
| October 24, 2024 | 655.39M |
| October 23, 2024 | 665.68M |
| October 22, 2024 | 664.79M |
| October 21, 2024 | 651.80M |
| October 18, 2024 | 646.88M |
| Date | Value |
|---|---|
| October 17, 2024 | 635.69M |
| October 16, 2024 | 658.52M |
| October 15, 2024 | 640.17M |
| October 14, 2024 | 650.91M |
| October 11, 2024 | 649.12M |
| October 10, 2024 | 618.23M |
| October 09, 2024 | 629.42M |
| October 08, 2024 | 633.00M |
| October 07, 2024 | 628.53M |
| October 04, 2024 | 633.90M |
| October 03, 2024 | 605.25M |
| October 02, 2024 | 630.32M |
| October 01, 2024 | 591.37M |
| September 30, 2024 | 588.68M |
| September 27, 2024 | 577.18M |
| September 26, 2024 | 571.38M |
| September 25, 2024 | 575.84M |
| September 24, 2024 | 577.18M |
| September 23, 2024 | 582.08M |
| September 20, 2024 | 611.94M |
| September 19, 2024 | 623.98M |
| September 18, 2024 | 604.81M |
| September 17, 2024 | 637.79M |
| September 16, 2024 | 579.85M |
| September 13, 2024 | 612.39M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
123.59M
Minimum
Mar 22 2023
2.198B
Maximum
Dec 17 2020
861.29M
Average
664.36M
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 3.517M |
| Palatin Technologies Inc | 18.35M |
| iBio Inc | 22.42M |
| Theriva Biologics Inc | 3.562M |
| Oragenics Inc | 3.305M |
Market Cap Related Metrics
| PS Ratio | 5.258 |
| PEG Ratio | -0.823 |
| Price to Book Value | 4.894 |
| Price | 10.10 |
| Earnings Yield | -5.35% |
| PEGY Ratio | -0.823 |